INTRODUCTION AND OBJECTIVES: Penile Cancer guidelinebased care for patients with invasive high risk primary tumors recommends the use of dynamic sentinel lymph node biopsy (DSNB) or superficial inguinal lymph node dissection (SILND) as inguinal staging tools. We present the first multi-institutional review of the use of SILND in the high-risk penile cancer patient.
METHODS: A retrospective review was performed among patients treated at the University of Texas MD Anderson Cancer Center in Houston, Texas and the H. Lee Moffitt Cancer Center in Tampa, FL. High risk penile cancer was defined as pathologic stage ! T1b and with palpably negative inguinal exams who underwent open bilateral SILND. Subsequent to frozen section analysis, patients with microscopic metastases underwent ipsilateral completion inguinal (and in some cases pelvic) lymph node dissection. Complications were evaluated based on the Clavien-Dindo classification system. RESULTS: 82 patients were identified who met the inclusion criteria. The median age at presentation was 59.5 (26-83). Clinical and pathological characteristics are listed in Table 1 . A total of 6 patients (7.3%) had positive nodes on SILND. At a median follow-up of 68 months (1-241), a total of 2 (2.6%) inguinal recurrences were noted, all in pN0 patients. An additional 3 patients (3.9%) developed distant metastatic disease. Surgical complications were appreciated in 33 (40.2%) patients and outlined in Table 2 . 7.4% of patients had multiple complications. The most common complications were wound infection and lymphocele (18 patients, 22.2%). The were 12 (30%) Clavien grade III complications identified. Of the 6 patients with pNþ disease, 3 (50%) had complications.
CONCLUSIONS: SILND is an effective staging tool to identify patients harboring microscopic inguinal metastases from penile cancer with a low rate of false negative findings. Surgical morbidity is greater than for DSNB and further prospective studies comparing the two modalities are needed.
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PD56-11 RADIOTHERAPY PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN PENILE CANCER PATIENTS WITH EXTRACAPSULAR NODAL EXTENSION AFTER INGUINAL LYMPH NODE SURGERY: A MULTI-INSTITUTIONAL STUDY
INTRODUCTION AND OBJECTIVES:
Because there is a lack of evidence, it is not generally recommended to use adjuvant radiotherapy plus chemotherapy to treat lymph node disease in penile cancer. The aim of this study was to determine the benefit of using adjuvant radiotherapy after inguinal surgery for penile cancer.
METHODS: Multi-institutional data were obtained from a total of 9 centers from April 2003 to April 2015 and retrospectively analyzed. pN3 patients with an extracapsular nodal extension who received adjuvant therapy after inguinal surgery were included. Cancer-speciï: c survival (CSS) was estimated using the Kaplan-Meier method. The multivariate analysis was performed using a Cox proportional hazards model. RESULTS: A total of 93 pN3 patients met the inclusion criteria. During the study period, 32 (34.4%) and 61 (65.6%) of these patients received adjuvant radiotherapy plus chemotherapy (ARþAC) or Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e1021
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